Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2010
12/29/2010CN101160413B Kit for detecting the antibody of HCV and its detecting method
12/29/2010CN101113424B Coleoptera pest efficient Bacillus thuringiensis cry8G gene, protein and uses thereof
12/29/2010CN101090963B Melibiose operon expression system
12/29/2010CN101070543B Super spirial plasmid separation purifying process
12/29/2010CN101067127B Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
12/29/2010CN101054411B Corn calcium adjusting phosphatase B analogy albumen, coding gene and application thereof
12/29/2010CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
12/29/2010CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010CA2766349A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
12/29/2010CA2766075A1 Methods for agrobacterium-mediated transformation of sugar cane
12/29/2010CA2766009A1 Variant lipolytic enzymes with improved expression, functionality and/or activity
12/29/2010CA2765915A1 Novel drugs for inhibition of gene expression
12/29/2010CA2765889A1 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
12/29/2010CA2765833A1 Modified biotin-binding protein
12/29/2010CA2765815A1 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
12/29/2010CA2765727A1 Stabilizing alkylglycoside compositions and methods thereof
12/29/2010CA2765560A1 Mutation that increases the oleic acid content in soybean oil and responsible gene thereof
12/29/2010CA2765108A1 Truncated actriib-fc fusion proteins
12/29/2010CA2764729A1 Expression of surrogate light chains
12/28/2010US7858855 Inbred maize variety PHCJM
12/28/2010US7858854 Plants and seed of inbred corn variety DS-046358
12/28/2010US7858853 Inbred corn line CC1
12/28/2010US7858852 Soybean variety XB16E09
12/28/2010US7858851 Soybean variety XB17G09
12/28/2010US7858850 Soybean cultivar S07-04JR000474
12/28/2010US7858849 Nucleotide sequences coding insecticidal protein for use in generation of insect resistant plants
12/28/2010US7858848 Transcription factors for increasing yield
12/28/2010US7858847 Protein kinase stress-related proteins and methods of use in plants
12/28/2010US7858846 introducing into proginator cells of the plant a plant transformation vector containing a nucleotide sequence that encodes or is complementary to a sequence that encodes a High Oil polypeptide; transgenic plants; seed oil
12/28/2010US7858845 Sugar and lipid metabolism regulators in plants IV
12/28/2010US7858844 Non-human transgenic organism comprising transgene coding non-aggregating chromo- or fluorescent Cnidarian chromo- or fluorescent protein; chemiluminescent labels and molecular biology
12/28/2010US7858771 Chemically modified short interfering nucleic acid molecule for use in treatment of respiratory and pulmonary disease
12/28/2010US7858769 RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA)
12/28/2010US7858767 Regulatory sequences useful for production of plants with modified embryo and/or endosperm development
12/28/2010US7858766 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection
12/28/2010US7858765 OX40R binding agents
12/28/2010US7858764 Cotton event MON15985 and compositions and methods for detection thereof
12/28/2010US7858762 Expression vector comprising nucleotide sequences coding osmosensitive (os-6) protein for use as tool in enhancing propagation in transgenic bacillus
12/28/2010US7858754 Nel-related protein type 1 antibody
12/28/2010US7858753 Immunoglobulins
12/28/2010US7858745 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
12/28/2010US7858742 Lymphoma associated molecules and uses therefor
12/28/2010US7858592 inhibition of p53 transcription by interfering with the activity of a p53 promoter using inhibitory double-stranded RNAs; use of these inhibitory RNAs in the treatment of cancers
12/28/2010US7858591 Oligonucleotide sequences which bind biomolecules such as peptides; selectively bind coagulation factors, E2F family members, Ang1 or Ang2; hydrophobic molecules and extracellular proteins for diagnosing and treating cardiovascular disorders in mammals
12/28/2010US7858590 Treatment of parkinson's disease and related disorders
12/28/2010US7858589 A saponin possessing immune adjuvant activity, derived from Quillaja saponaria; an immunostimulatory oligonucleotide cotaining an unmethylated CpG dinucleotide,wherein the immunostimulatory oligonucleotide is not a part of a DNA vaccine vector
12/28/2010US7858588 Oligodeoxynucleic acid modified with (thio)phosphate
12/28/2010US7858576 Method for targeting lysosomal enzymes
12/28/2010US7858559 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
12/28/2010US7858370 Plasmid for efficient transformation and generation of disease, insect and herbicide resistant plants
12/28/2010US7858369 Expression constructs expressing Prkag3
12/28/2010US7858368 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars
12/28/2010US7858367 includes a deleted adenovirus vector genome having the adenovirus 5' and 3' cis-elements for viral replication and encapsidation and a recombinant adeno-associated virus (AAV) vector genome flanked by the adenovirus vector genome sequences; for gene therapy
12/28/2010US7858364 Apparatus and method for polymer synthesis using arrays
12/28/2010US7858361 Commercialization of LK8 protein as a novel angiogenesis inhibitor; culturing
12/28/2010US7858360 Use of fungal mutants for expression of antibodies
12/28/2010US7858358 Rapid growing microorganisms for biotechnology applications
12/28/2010US7858357 Immunization with bacterial ghost-based vaccines
12/28/2010US7858356 Mutant paramyxovirus and method for production thereof
12/28/2010US7858355 Dimeric glycerol dehydratases
12/28/2010US7858354 Serine protease for enhancing washing performance of detergents; laundry and dishwashing; isolated from Bacillus strains
12/28/2010US7858353 nucleic acid sequence encoding a polypeptide that exhibits Alpha-L-Arabinofuranosidase activity; degrading, cleaving, or removing polysaccharides including cellulose
12/28/2010US7858352 Polypeptide
12/28/2010US7858346 Regeneration and neogenesis of retinal visual cell-expressing Otx2 protein
12/28/2010US7858341 using an E. coli expression system for the large scale production of FGF18 (fibroblast growth factors); improved methods for producing biologically active and purified recombinant FGF18
12/28/2010US7858340 Polynucleotides and methods of directing the ratio of B2:B1 avermectins in Streptomyces avermitilis host cells
12/28/2010US7858339 Refractile particles containing a heterologous polypeptide as an insoluble aggregate are recovered from bacterial periplasm; allows use of phage lysozyme at high cell density and increased scale; Chloroform is not used in any step and the recovery step minimizes co-recovery of cellular debris
12/28/2010US7858335 Microorganisms and assays for the identification of antibiotics
12/28/2010US7858334 Using sterospecific carboxylesterase variant for bioremediation of pyrethroids; eliminating or reducing the concentration of a pyrethroid pesticide in a sample
12/28/2010US7858326 Immunoglobulin specific to eotaxin for use in diagnosis, prevention and treatment of infections, autoimmune, inflammatory and allergic disorders; chemotactic cytokines designated human eotaxins; selectively modulate leukocyte function
12/28/2010US7858323 Phage microarray profiling of the humoral response to disease
12/28/2010US7858321 Methods and apparatus for conducting multiple measurements on a sample
12/28/2010US7858318 Methods and compositions for vitamin K epoxide reductase
12/28/2010US7858312 Method of treating bladder and lower urinary tract syndromes
12/28/2010US7858304 Gene expression profiling in biopsied tumor tissues
12/28/2010US7858302 Real time nucleic acid detection allows for the qualitative or quantitative detection or determination of single-stranded or double-stranded nucleic acids of interest in a sample; for removing a portion of a homopolymeric sequence from an analyte or library of analytes
12/28/2010US7858300 Methods and compositions to evaluate antibody treatment response
12/28/2010US7858297 Chemokine-binding protein and methods of use
12/28/2010US7858096 Mutant forms of meningococcal ADP-ribosylating toxin
12/28/2010US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response
12/28/2010US7858091 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
12/28/2010US7858090 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
12/28/2010US7858088 chimeric anti-EGP-2-binding scFv fragment 4D5MOC-A; for treatment of human carcinomas; Pseudomonas exotoxin A
12/28/2010US7858086 Biopolymer mixture for use in diagnosis, prevention and treatment of acute myeloid leukemia
12/28/2010US7858083 Recombinant viral vector comprising antitumor agents for use in targeted tissue therapy; gene therapy; Replication-competent adenoviral vectors which selectively replicate in cancer cells
12/23/2010WO2010148334A2 Generation of induced pluripotent stem cells from cord blood
12/23/2010WO2010148223A2 Anti-vegf antibodies and their uses
12/23/2010WO2010148212A2 Short telomere length on chromosome 9p is strongly associated with breast cancer risk
12/23/2010WO2010148203A2 Producer cells for replication competent retroviral vectors
12/23/2010WO2010148148A2 β-GLUCOSIDASE VARIANTS
12/23/2010WO2010148140A2 Stable plasmid expression vector for bacteria
12/23/2010WO2010148085A1 Rna nanoparticles and methods of use
12/23/2010WO2010148065A2 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
12/23/2010WO2010148050A2 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
12/23/2010WO2010148039A2 Methods and compositions for long fragment read sequencing
12/23/2010WO2010147992A1 Methods for increasing efficacy of lipid formulated sirna
12/23/2010WO2010147989A1 Compositions and methods for the isolation of nucleic acid
12/23/2010WO2010147971A2 Il23 modified viral vector for recombinant vaccines and tumor treatment
12/23/2010WO2010147907A1 High eicosapentaenoic acid oils from improved optimized strains of yarrowia lipolytica
12/23/2010WO2010147825A1 Early endosperm promoter and methods of use
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 4023